Duration of opiate receptor blockade determines tumorigenic response in mice with neuroblastoma: A role for endogenous opioid systems in cancer
- 1 July 1984
- journal article
- research article
- Published by Elsevier in Life Sciences
- Vol. 35 (4), 409-416
- https://doi.org/10.1016/0024-3205(84)90651-9
Abstract
No abstract availableFunding Information
- National Institutes of Health (NS-20623)
This publication has 14 references indexed in Scilit:
- Opioid antagonists inhibit the growth of metastatic murine neuroblastomaCancer Letters, 1983
- Naltrexone Modulates Tumor Response in Mice with NeuroblastomaScience, 1983
- Enkephalins as immunomodulatorsInternational Journal of Immunopharmacology, 1983
- Naltrexone-induced opiate receptor supersensitivityBrain Research, 1982
- Heroin prolongs survival time and retards tumor growth in mice with neuroblastomaBrain Research Bulletin, 1981
- Naloxone prolongs the survival time of mice treated with neuroblastomaLife Sciences, 1981
- Naltrexone reduces weight gain, alters “β-endorphin”, and reduces insulin output from pancreatic islets of genetically obese micePeptides, 1980
- On the specificity of naloxone as an opiate antagonistLife Sciences, 1979
- Chronic naloxone results in prolonged increases in opiate binding sites in brainEuropean Journal of Pharmacology, 1978
- Enhanced analgesic effects of morphine after chronic administration of naloxone in the ratEuropean Journal of Pharmacology, 1978